ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.
Follow-Up Questions
Thermogenesis Holdings Inc (THMO) の株価収益率はいくらですか?
Thermogenesis Holdings Inc の株価収益率は 0 です。
Thermogenesis Holdings Inc のCEOは誰ですか?
Dr. Xiaochun Xu は Thermogenesis Holdings Inc の Chairman of the Board で、2016 から在籍しています。
THMO の株価パフォーマンスは?
THMO の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Thermogenesis Holdings Inc の主な事業テーマや業界は?
Thermogenesis Holdings Inc は Health Care 業界、セクターは Health Care に属しています。